NEGEV CAPITAL

negev-capital-logo

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.

#SimilarOrganizations #People #Financial #More

NEGEV CAPITAL

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2021-01-07

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

Current Employees Featured

ken-belotsky_image

Ken Belotsky
Ken Belotsky Partner @ Negev Capital
Partner
2021-05-01

Investments List

Date Company Article Money raised
2022-02-10 Mindstate Design Labs Negev Capital investment in Seed Round - Mindstate Design Labs 11.5 M USD
2021-09-27 Delix Therapeutics Negev Capital investment in Series A - Delix Therapeutics 70 M USD
2021-09-21 MycroDose Therapeutics Negev Capital investment in Seed Round - MycroDose Therapeutics N/A
2021-08-15 Beckley Psytech Negev Capital investment in Series B - Beckley Psytech 58 M GBP
2021-06-29 NanoPsy Negev Capital investment in Seed Round - NanoPsy 500 K CAD

More informations about "Negev Capital" on Search Engine